Identification of a novel, selective GABAA α5 receptor inverse agonist which enhances cognition

被引:128
|
作者
Chambers, MS [1 ]
Atack, JR [1 ]
Broughton, HB [1 ]
Collinson, N [1 ]
Cook, S [1 ]
Dawson, GR [1 ]
Hobbs, SC [1 ]
Marshall, G [1 ]
Maubach, KA [1 ]
Pillai, GV [1 ]
Reeve, AJ [1 ]
MacLeod, AM [1 ]
机构
[1] Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
关键词
D O I
10.1021/jm020582q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In pursuit of a GABA(A) alpha5-subtype-selective inverse agonist to enhance cognition, a series of 6,7-dihydro-2-benzothiophen-4(5H)-ones has been identified as a novel class of GABAA receptor ligands. These thiophenes have higher binding affinity for the GABA(A) alpha(5) receptor subtype compared to the GABA(A) alpha(1), alpha(2), and alpha(3) subtypes, and several analogues exhibit high GABA(A) (alpha(5) receptor inverse agonism. 6,6-Dimethyl-3-(2-hydroxyethyl)thio-1-(thiazol-2-yl)-6,7-dihydro2-benzothiophen-4(5H)-one (43) has been identified as a full inverse agonist at the GABA(A) alpha5 receptor and is functionally selective over the other major GABA(A) receptor subtypes. 43 readily penetrates into the CNS to give selective occupancy of GABA(A) alpha5 receptors. In addition, 43 enhances cognitive performance in rats in the delayed 'matching-to-place' Morris water maze test-a hippocampal-dependent memory task-without the convulsant or proconvulsant activity associated with nonselective, GABA(A) receptor inverse agonists.
引用
收藏
页码:2227 / 2240
页数:14
相关论文
共 50 条
  • [1] An inverse agonist selective for α5 subunit-containing GABAA receptors enhances cognition
    Dawson, GR
    Maubach, KA
    Collinson, N
    Cobain, M
    Everitt, BJ
    MacLeod, AM
    Choudhury, HI
    McDonald, LM
    Pillai, G
    Rycroft, W
    Smith, AJ
    Sternfeld, F
    Tattersall, FD
    Wafford, KA
    Reynolds, DS
    Seabrook, GR
    Atack, JR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03): : 1335 - 1345
  • [2] An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA α5 receptors with cognition enhancing properties
    Chambers, MS
    Atack, JR
    Carling, RW
    Collinson, N
    Cook, SM
    Dawson, GR
    Ferris, P
    Hobbs, SC
    O'Connor, D
    Marshall, G
    Rycroft, W
    MacLeod, AM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) : 5829 - 5832
  • [3] Preclinical and clinical pharmacology of the GABAA receptor α5 subtype-selective inverse agonist α5IA
    Atack, John R.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2010, 125 (01) : 11 - 26
  • [4] GABAA receptor inverse agonist fails to improve cognition in Alzheimer's disease patients
    Tolar, M
    Cassella, J
    Villalobos, A
    Bednar, M
    Weaver, J
    Davidson, W
    Gibbs, M
    Weiner, M
    Solomon, P
    [J]. NEUROLOGY, 2004, 62 (07) : A319 - A319
  • [5] Effects of a novel inverse agonist selective for alpha5 GABAA receptors on spatial memory: comparison with the standard non-selective inverse agonist DMCM
    Samardzic, J.
    Savic, M. M.
    Clayton, T.
    Rallapalli, S.
    Obradovic, D. I.
    Joksimovic, S. M.
    Sieghart, W.
    Cook, J. M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S285 - S285
  • [6] Discovery of GABAA α5 subtype selective inverse agonists as cognition enhancers.
    MacLeod, AM
    Dawson, GR
    Pillai, G
    Cook, S
    Atack, JR
    Reeve, AJ
    Jelley, RA
    Carling, R
    Street, LJ
    McKernan, LJ
    Wafford, K
    Laughton, P
    Hill, R
    Collinson, N
    Whiting, P
    Castro, JL
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U33 - U33
  • [7] Selective GABAA α5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol
    Cook, JB
    Foster, KL
    Eiler, WJA
    McKay, PF
    Woods, J
    Harvey, SC
    Garcia, M
    Grey, C
    McCane, S
    Mason, D
    Cummings, R
    Li, XY
    Cook, JM
    June, HL
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (08) : 1390 - 1401
  • [8] GABAA Receptor Subtype-Selective Modulators. II. α5-Selective Inverse Agonists for Cognition Enhancement
    Atack, John R.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (09) : 1203 - 1214
  • [9] GABAA Receptor Subtype Selective Cognition Enhancers
    Maubach, Karen
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (04) : 233 - 239
  • [10] Aldehyde oxidase and its contribution to the metabolism of a structurally novel, functionally selective GABAA α5-subtype inverse agonist
    O'Connor, D.
    Jones, P.
    Chambers, M. S.
    Maxey, R.
    Szekeres, H. J.
    Szeto, N.
    Scott-Stevens, P.
    Macleod, A. M.
    Braun, M.
    Cato, B.
    [J]. XENOBIOTICA, 2006, 36 (04) : 315 - 330